Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 16.240% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a COc1ccccc1C(=O)NC(C(=O)NCCc1nc2ccccc2[nH]1)=C(C)C
b Cc1cc(C)c(CN2CCC(n3nccc3NC(=O)C3CCOC3)CC2)cc1C
c C=CCN1C(=O)C2(OCCO2)c2cc(C)ccc21
Answer: a. COc1ccccc1C(=O)NC(C(=O)NCCc1nc2ccccc2[nH]1)=C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccccc1C(=O)NC(C(=O)NCCc1nc2ccccc2[nH]1)=C(C)C
COc1ccccc1C(=O)NC(C(=O)NCCc1nc2ccccc2[nH]1)=C(C)C
N-[1-[2-(1H-benzimidazol-2-yl)ethylamino]-3-methyl-1-oxobut-2-en-2-yl]-2-methoxybenzamide